- Home
- KROS vs HTBI Comparison
KROS vs HTBI Comparison
Compare KROS & HTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- HTBI
- Stock Information
- Founded
- KROS 2015
- HTBI 1926
- Country
- KROS United States
- HTBI United States
- Employees
- KROS N/A
- HTBI N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- HTBI Savings Institutions
- Sector
- KROS Health Care
- HTBI Finance
- Exchange
- KROS Nasdaq
- HTBI Nasdaq
- Market Cap
- KROS 460.6M
- HTBI 641.9M
- IPO Year
- KROS 2020
- HTBI 2012
- Fundamental
- Price
- KROS $11.00
- HTBI $37.25
- Analyst Decision
- KROS Buy
- HTBI Buy
- Analyst Count
- KROS 11
- HTBI 4
- Target Price
- KROS $45.33
- HTBI $39.00
- AVG Volume (30 Days)
- KROS 2.1M
- HTBI 42.1K
- Earning Date
- KROS 02-26-2025
- HTBI 01-23-2025
- Dividend Yield
- KROS N/A
- HTBI 1.30%
- EPS Growth
- KROS N/A
- HTBI N/A
- EPS
- KROS N/A
- HTBI 3.20
- Revenue
- KROS $651,000.00
- HTBI $193,436,000.00
- Revenue This Year
- KROS $303.27
- HTBI N/A
- Revenue Next Year
- KROS N/A
- HTBI $3.67
- P/E Ratio
- KROS N/A
- HTBI $11.33
- Revenue Growth
- KROS 8037.50
- HTBI 4.69
- 52 Week Low
- KROS $9.78
- HTBI $23.55
- 52 Week High
- KROS $73.00
- HTBI $38.99
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- HTBI 61.69
- Support Level
- KROS $11.04
- HTBI $35.68
- Resistance Level
- KROS $11.99
- HTBI $38.22
- Average True Range (ATR)
- KROS 0.60
- HTBI 1.07
- MACD
- KROS 1.20
- HTBI 0.30
- Stochastic Oscillator
- KROS 43.99
- HTBI 81.24
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About HTBI HomeTrust Bancshares Inc.
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products.